Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

AbbVie Stock News

ABBVNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$176.80

-0.66-0.37%

At close: -

$175.92

-0.88-0.50%

After Hours: 6:37 PM EDT

Q1 2025 Earnings in 10 days from now on Fri Apr 25th, before the market open

AbbVie (ABBV) Forecast

News

Earnings AbbVie (ABBV) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest AbbVie Stock News | NYSE:ABBV | Benzinga

Get the latest news on AbbVie stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on AbbVie performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, April 15, 2025

AbbVie Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights - 10 hours ago
34-Year-Old Making $3,400 a Month in Dividends Shares His Top 7 Stocks — 'Be Lucky and Save Relentlessly'
Fahad Saleem - 23 hours ago

Monday, April 14, 2025

Meta, TJX, Taiwan Semiconductor Manufacturing And A Health Care Stock: CNBC's 'Final Trades'
Avi Kapoor - 1 day ago

Friday, April 11, 2025

AbbVie Unusual Options Activity
Benzinga Insights - 4 days ago
Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight
Vandana Singh - 4 days ago
CNBC Halftime Report Final Trades: Meta Platf...
Benzinga Newsdesk - 4 days ago
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Rishabh Mishra - 4 days ago

Wednesday, April 09, 2025

Tech Stocks Rebound As US Treasuries Tumble: What's Driving Markets Wednesday?
Piero Cingari - 6 days ago
Morgan Stanley Maintains Overweight on AbbVie...
Benzinga Newsdesk - 6 days ago

Tuesday, April 08, 2025

Goldman Sachs Assumes AbbVie at Neutral, Anno...
Benzinga Newsdesk - Apr 8, 2025, 12:08PM
AbbVie's RINVOQ Receives European Commission ...
Benzinga Newsdesk - Apr 8, 2025, 3:07AM

Thursday, April 03, 2025

AbbVie Q1 2025 Earnings Include $248M IPR&D A...
Benzinga Newsdesk - Apr 3, 2025, 4:19PM
Trump's Tariff Exemptions Include Semiconductors, Pharmaceuticals, Oil And More
Erica Kollmann - Apr 3, 2025, 12:30PM

Tuesday, April 01, 2025

Looking At AbbVie's Recent Unusual Options Activity
Benzinga Insights - Apr 1, 2025, 2:45PM

Monday, March 31, 2025

Decoding AbbVie's Options Activity: What's the Big Picture?
Benzinga Insights - Mar 31, 2025, 3:01PM
Meta, Snowflake, PayPal And Health Care Stock On CNBC's 'Final Trades'
Avi Kapoor - Mar 31, 2025, 8:46AM

Friday, March 28, 2025

CNBC Halftime Report Final Trades: PayPal Hol...
Benzinga Newsdesk - Mar 28, 2025, 1:01PM

Thursday, March 27, 2025

Retired At 58, He 'Spent Between $1M-$2M On Stocks' – Investor Who Built An 8% Yield Portfolio And Lives Off Dividends Shares Top Holdings
Paula Tudoran - Mar 27, 2025, 12:01PM
From Rookie Mistakes To $10K/Year In Dividends – Military Veteran Who 'Made A Few Great Plays' Shares His 10 Biggest Bets
Paula Tudoran - Mar 27, 2025, 10:15AM

Wednesday, March 26, 2025

Collplant Announces Six-Month Study Data From...
Benzinga Newsdesk - Mar 26, 2025, 8:08AM

Tuesday, March 25, 2025

Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside
Vandana Singh - Mar 25, 2025, 3:20PM
Smart Money Is Betting Big In ABBV Options
Benzinga Insights - Mar 25, 2025, 11:45AM

Monday, March 24, 2025

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Benzinga Insights - Mar 24, 2025, 10:00AM
Reported Friday, Genmab Refutes AbbVie's Trad...
Benzinga Newsdesk - Mar 24, 2025, 1:41AM

Friday, March 21, 2025

Is AbbVie Gaining or Losing Market Support?
Benzinga Insights - Mar 21, 2025, 4:15PM
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights - Mar 21, 2025, 1:35PM

Thursday, March 20, 2025

AbbVie Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights - Mar 20, 2025, 4:00PM
Live On CNBC, Josh Brown Hosts Segment Titled...
Benzinga Newsdesk - Mar 20, 2025, 12:42PM

Monday, March 17, 2025

AbbVie's Elahere Cuts Death Risk By 32%, Shows Consistent Survival Benefit In Long-Term Analysis For Certain Ovarian Cancer Patients
Vandana Singh - Mar 17, 2025, 2:02PM
Reported Saturday, AbbVie Highlights Final MI...
Benzinga Newsdesk - Mar 17, 2025, 3:22AM

Tuesday, March 11, 2025

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights - Mar 11, 2025, 1:35PM

Friday, March 07, 2025

AbbVie Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights - Mar 7, 2025, 3:30PM

Wednesday, March 05, 2025

Wells Fargo Maintains Overweight on AbbVie, R...
Benzinga Newsdesk - Mar 5, 2025, 10:13AM

Tuesday, March 04, 2025

13 Analysts Have This To Say About AbbVie
Benzinga Insights - Mar 4, 2025, 5:00PM
B of A Securities Maintains Neutral on AbbVie...
Benzinga Newsdesk - Mar 4, 2025, 10:03AM
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Benzinga Insights - Mar 4, 2025, 9:15AM
AbbVie Announces SKYRIZI Available In Canada ...
Benzinga Newsdesk - Mar 4, 2025, 8:08AM

Monday, March 03, 2025

AbbVie Becomes Another Big Pharma To Enter Obesity Treatment Race
Vandana Singh - Mar 3, 2025, 2:07PM
CNBC Halftime Report Final Trades: Taiwan Sem...
Benzinga Newsdesk - Mar 3, 2025, 1:01PM
AbbVie Enters Obesity Market with ~$2.2B Gubr...
Benzinga Newsdesk - Mar 3, 2025, 1:31AM

Friday, February 28, 2025

AbbVie's RINVOQ Gains CHMP Backing For Giant ...
Benzinga Newsdesk - Feb 28, 2025, 2:11AM

Thursday, February 27, 2025

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights - Feb 27, 2025, 12:35PM

Monday, February 24, 2025

Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
Benzinga Insights - Feb 24, 2025, 5:00PM

Tuesday, February 18, 2025

Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich
Rishabh Mishra - Feb 18, 2025, 5:02AM

Monday, February 17, 2025

How Is The Market Feeling About AbbVie?
Benzinga Insights - Feb 17, 2025, 12:30PM

Friday, February 14, 2025

AbbVie Board Elected Robert A. Michael To Suc...
Benzinga Newsdesk - Feb 14, 2025, 7:33AM

Wednesday, February 12, 2025

Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?
Vandana Singh - Feb 12, 2025, 10:44AM
AbbVie And Xilio Therapeutics Announced A Col...
Benzinga Newsdesk - Feb 12, 2025, 7:33AM

Friday, February 07, 2025

U.S. FDA Approves EMBLAVEO For The Treatment ...
Benzinga Newsdesk - Feb 7, 2025, 1:28PM

Wednesday, February 05, 2025

Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase
Avi Kapoor - Feb 5, 2025, 8:20AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved